APA

Burger D. M., Aarnoutse R. E., Dieleman J. P., Gyssens I. C., Nouwen J., de Marie S., Koopmans P. P., Stek M. & van der Ende M. E. (20040209). A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study). : Antiviral therapy.

Chicago

Burger David M, Aarnoutse Rob E, Dieleman Jeanne P, Gyssens Inge C, Nouwen Jan, de Marie Siem, Koopmans Peter P, Stek Michael and van der Ende Marcina E. 20040209. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study). : Antiviral therapy.

Harvard

Burger D. M., Aarnoutse R. E., Dieleman J. P., Gyssens I. C., Nouwen J., de Marie S., Koopmans P. P., Stek M. and van der Ende M. E. (20040209). A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study). : Antiviral therapy.

MLA

Burger David M, Aarnoutse Rob E, Dieleman Jeanne P, Gyssens Inge C, Nouwen Jan, de Marie Siem, Koopmans Peter P, Stek Michael and van der Ende Marcina E. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study). : Antiviral therapy. 20040209.